Skip to main content
Log in

Erste placebo-kontrollierte Studie zum fäkalen Mikrobiota-Transfer (FMT) beim Reizdarmsyndrom

Faecal microbiota transplantation versus placebo for moderate-to-severe irritable bowel syndrome

  • Journal Club
  • Published:
coloproctology Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Rodino-Janeiro BK et al (2018) A Review of Microbiota and Irritable Bowel Syndrome: Future in Therapies. Adv Ther. https://doi.org/10.1007/s12325-018-0673-5

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to H. Krammer.

Ethics declarations

Interessenkonflikt

Y. Alt und J. Brandt geben an, dass kein Interessenkonflikt besteht.

Additional information

Die Zusammenfassung der Studie ist die Übersetzung des englischen Abstracts der Originalpublikation.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Alt, Y., Brandt, J. & Krammer, H. Erste placebo-kontrollierte Studie zum fäkalen Mikrobiota-Transfer (FMT) beim Reizdarmsyndrom. coloproctology 40, 377–379 (2018). https://doi.org/10.1007/s00053-018-0287-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00053-018-0287-z

Navigation